2017
DOI: 10.1093/eurheartj/ehx684
|View full text |Cite
|
Sign up to set email alerts
|

Matrix metalloproteinase-9 might affect adaptive immunity in non-ST segment elevation acute coronary syndromes by increasing CD31 cleavage on CD4+ T-cells

Abstract: AimsIn patients with acute coronary syndrome (ACS), the higher activity of effector T-cells suggests that mechanisms involving adaptive immunity dysregulation might play a role in coronary instability. The shedding of the functional CD31 domain 1–5 leads to uncontrolled lymphocyte activation. In experimental models, matrix metalloproteinase-9 (MMP-9) has been implicated in endothelial CD31 cleavage. Interestingly, higher serum levels of MMP-9 have been observed in ACS. We aim to investigate the mechanisms unde… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(20 citation statements)
references
References 30 publications
0
19
0
Order By: Relevance
“…To date, interventional trials designed to investigate whether periodontal treatment results in overall improvement of cardiovascular parameters have yet to demonstrate any causal relationships between these two disease groups, and thus additional more precisely designed studies are needed (14). Increased (blood) levels of matrix metalloproteinases (MMP) are associated with an increase in the incidence of MI and may be a predictive marker for future CAD (18). Eventually it might be possible to use OIL in a predictive way to help identify individuals at risk for CAD and the subsequent development of other cardiovascular disease conditions.…”
Section: Discussionmentioning
confidence: 99%
“…To date, interventional trials designed to investigate whether periodontal treatment results in overall improvement of cardiovascular parameters have yet to demonstrate any causal relationships between these two disease groups, and thus additional more precisely designed studies are needed (14). Increased (blood) levels of matrix metalloproteinases (MMP) are associated with an increase in the incidence of MI and may be a predictive marker for future CAD (18). Eventually it might be possible to use OIL in a predictive way to help identify individuals at risk for CAD and the subsequent development of other cardiovascular disease conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, higher serum levels of MMP-9 have been observed in acute coronary syndrome. 19 The ratio between the domains was significantly lower in ACS than in stable angina or in controls.…”
mentioning
confidence: 89%
“…Of interest, CD31 extracellular domain is shed from the lymphocyte surface during ACS and this contributes to the over activation of adaptive immunity[ 19 ]. In their recent article, Angelini et al[ 10 ] added one more piece to this puzzle by showing matrix metalloproteinase (MMP)-9 to be involved in CD31 cleavage in lymphocytes from ACS patients. Firstly, they confirm CD31 shedding to be a specific feature of lymphocytes in ACS, as compared to samples from healthy subjects but also patients with stable angina (SA).…”
Section: Mmp-9 and Cd31: A Dangerous Associationmentioning
confidence: 99%
“…Finally, after observing CD31 to be a possible substrate for MMP-9 by using an dedicated software predicting novel substrates and their cleavage sites, the authors show lymphocytes from ACS patients to produce higher enzyme levels after stimulation and CD31 active domain to be preserved by MMP-9 inhibition. Based on these results, the authors propose a new sequence of events that might characterize ACS onset in which the increased release of MMP-9 causes CD31 cleavage, thus affecting TCR-dependent T-cell activation and causing T-cell hyperactivity[ 10 ].…”
Section: Mmp-9 and Cd31: A Dangerous Associationmentioning
confidence: 99%
See 1 more Smart Citation